SOPHiA GENETICS Management
Management criteria checks 3/4
SOPHiA GENETICS' CEO is Jurgi Camblong, appointed in Mar 2011, has a tenure of 13.75 years. directly owns 3.7% of the company’s shares, worth $8.27M. The average tenure of the management team and the board of directors is 3.9 years and 4.5 years respectively.
Key information
Jurgi Camblong
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.8yrs |
| CEO ownership | 3.7% |
| Management average tenure | 3.9yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target
Aug 09Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)
Aug 08SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 09Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
Feb 12Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge
Nov 09Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
Sep 21SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
Aug 09We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 18We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$71m |
| Jun 30 2024 | n/a | n/a | -US$67m |
| Mar 31 2024 | n/a | n/a | -US$73m |
| Dec 31 2023 | n/a | n/a | -US$79m |
| Sep 30 2023 | n/a | n/a | -US$69m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$82m |
| Dec 31 2022 | US$3m | US$507k | -US$87m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$93m |
| Mar 31 2022 | n/a | n/a | -US$86m |
| Dec 31 2021 | US$8m | US$394k | -US$74m |
Compensation vs Market: Insufficient data to establish whether Jurgi's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Jurgi's compensation has been consistent with company performance over the past year.
CEO
Jurgi Camblong (46 yo)
13.8yrs
Tenure
US$3,332,361
Compensation
Dr. Jurgi Camblong, Ph D., M.B.A., serves as Chief Executive Officer and Director of SOPHiA GENETICS SA since March 2011. Dr. Camblong Co-founded SOPHiA GENETICS SA since March 2011.In 2010, Dr. Camblong...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$3.33m | 3.7% $ 8.3m | |
| President | less than a year | no data | 0.093% $ 206.8k | |
| Executive VP & CFO | less than a year | no data | no data | |
| Senior VP & CTO | 2.9yrs | no data | no data | |
| Executive VP & Chief Scientific Officer | 3.9yrs | no data | 0.62% $ 1.4m | |
| Head of Strategy and Investor Relations | no data | no data | no data | |
| Executive VP | 5.5yrs | no data | 0.14% $ 308.5k | |
| Executive VP & Chief People Officer | 5.9yrs | no data | 0.060% $ 134.1k | |
| VP & MD of EMEA | 1.3yrs | no data | no data | |
| Executive VP | 4.8yrs | no data | 0.063% $ 140.3k |
3.9yrs
Average Tenure
46yo
Average Age
Experienced Management: SOPH's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$3.33m | 3.7% $ 8.3m | |
| Independent Non-Executive Director | 3.9yrs | US$257.20k | 0.056% $ 125.7k | |
| Independent Non-Executive Director | 4.5yrs | US$265.94k | 0.11% $ 250.4k | |
| Independent Director | 2.9yrs | US$218.17k | 0.095% $ 213.1k | |
| Independent Non-Executive Director | 10.5yrs | US$233.53k | 0.60% $ 1.3m | |
| Independent Non-Executive Director | 3.8yrs | no data | no data | |
| Independent Non-Executive Chairman | 5.5yrs | US$290.93k | 0.28% $ 624.8k |
4.5yrs
Average Tenure
60yo
Average Age
Experienced Board: SOPH's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 23:03 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SOPHiA GENETICS SA is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Massaro | BTIG |
| William Bonello | Craig-Hallum Capital Group LLC |
| Katie Tryhane | Credit Suisse |